Prof. Wu Tiantian, MD
Hepatobiliary Surgeon
- Specialty :Precision minimally invasive liver resection for primary and metastatic liver cancer; radical and conversion surgeries for gallbladder and bile duct cancer; robotic-assisted minimally invasive surgery for pancreatic cancer and cystic pancreatic tumors; and minimally invasive treatment for gallstones and bile duct stones.
- Affiliated Hospital :Peking University International Hospital
- Department :Hepatobiliary Surgery
- Language :English, Chinese
Personal Introduction
Chief Physician, Associate Professor, and co-supervisor for doctoral students at Peking University Health Science Center. Specializing in minimally invasive surgery for hepatobiliary and pancreatic cancers, the physician is highly proficient in robotic-assisted hepatobiliary and pancreatic procedures. A key focus of their clinical practice is the conversion therapy for advanced biliary tract malignancies, with a commitment to facilitating surgical intervention for previously unresectable hepatobiliary tumors.
Achievements and Experience
He specializes in robotic minimally invasive hepatobiliary-pancreatic surgery. He has published SCI papers on conversion therapy for unresectable biliary tract tumors and has taken charge of multiple clinical research projects.
Main Academic Roles
- Member of the Biliary Tract Cancer Professional Committee, CSCO (Chinese Society of Clinical Oncology);
- Member of the International Hepato-Pancreato-Biliary Association (IHPBA);
- Deputy Secretary-General of the Hepato-Pancreato-Biliary Cancer Professional Committee, Beijing Health Promotion Association;
- Review Expert for the National Natural Science Foundation of China (NSFC)